iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function - Wikidata - wikimedia - TriplyDB

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

http://www.wikidata.org/entity/Q33947954

about

Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms EGF receptor ligands: recent advances In Vitro Model of the Epidermis: Connecting Protein Function to 3D Structure Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.iRhom2 mutation leads to aberrant hair follicle differentiation in mice.iRhoms; Its Functions and Essential Roles.Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16.Discovery in genetic skin disease: the impact of high throughput genetic technologies 150th Anniversary Series: Desmosomes and the Hallmarks of Cancer.Genetic deletion of amphiregulin restores the normal skin phenotype in a mouse model of the human skin disease tylosis Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.ADAM17/EGFR axis promotes transglutaminase-dependent skin barrier formation through phosholipase C γ1 and protein kinase C pathways.Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation.Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses.Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice.A hypomorphic Egfr allele does not ameliorate the palmoplantar keratoderma caused by SLURP1 deficiency.The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.Olmutinib-induced palmoplantar keratoderma.Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.p63 is a key regulator of iRHOM2 signalling in the keratinocyte stress response.MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis.Activation of stimulator of interferon genes (STING) induces ADAM17-mediated shedding of the immune semaphorin SEMA4D.

P2860

Q26784445-D8AF8927-4545-411F-A221-4D7F44B15390 Q28066531-8F4B85CE-0219-4554-92EA-73DD54A0DC71 Q28069458-42C45DDC-985F-4B18-B4DB-B435AC89297F Q33704501-6019E10A-7E6B-40DB-8719-40582EDD0A21 Q35535214-F7B9A6E5-864F-43D0-97B6-69D12673825A Q36640392-8390FA93-3651-421C-9B6B-02A8C92DD585 Q37622403-D6792193-CE0E-494B-9624-2891FD3E703E Q38237121-89D0A77B-FD87-4145-BF00-FBA8D1396B46 Q38541665-D65F59D9-6AE0-40BD-9191-C6588AC0BC4A Q38706195-32B35AA9-E78B-4036-967B-F4ADF652F732 Q38822173-5ED1A54A-8A03-4197-AAE9-4F4BEAF28EE5 Q38852399-679CED49-75A8-4708-8A91-CD6F0B612FE4 Q39683133-5A4381AA-CBED-46C0-8E94-7099E3430A0C Q39761331-D5804EF6-6940-4167-A439-99238C83B2AF Q40080379-651095C1-08B8-4C1E-B926-34401DE5F57F Q42615354-221AEF29-829B-4323-A2A7-6A476321D578 Q46102475-029F4FDD-3E5E-4096-80AC-4CBF0C59BD14 Q46457656-2DF5F48D-0E71-4817-A59E-F81666F85235 Q48132766-933A4C88-4D38-4D10-A551-8288F702A2AC Q50203153-6EB6E6C6-1556-4CB8-8B96-151C94949247 Q50420100-AD8D41AE-7798-4D16-BB72-815CA0E238CB Q51689102-4BB95D15-3340-4BFF-A44E-6C858E75F6EB Q52721580-104FBA54-9449-4511-BEC1-577823EB9746

P2860

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

http://www.wikidata.org/entity/Q33947954

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@ast

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@en

type

label

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@ast

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@en

prefLabel

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@ast

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@en

P1433

Q33947954-3C1C5CC3-E38D-4DBC-A611-CA27A47F832F

P1476

Q33947954-96445708-95D4-41ED-ADE9-E910DBE24234

P2093

Q33947954-1C31795E-0B72-4346-B48F-159B9FD8CA23

Q33947954-349A00A4-39A4-486A-B063-0305FBF9935E

Q33947954-51FBC5E3-02E9-4F1D-A19C-601AFA439255

Q33947954-CEF925CB-AEC8-4764-AC3E-B5D47A746890

Q33947954-EB700911-BA36-4CE5-B432-2ABA74C5AA5F

Q33947954-FCFFF807-B3FE-4DE4-B0EC-1F1848020F9E

P2860

Q33947954-06751660-7E60-4CAA-A3C6-08CABD181280

Q33947954-095B68C9-F83B-469E-A0A9-84471417AD5C

Q33947954-168076A6-42F5-49E9-B0D6-CD46AAE67B75

Q33947954-1DF06F0A-B74C-4880-B6B9-5E95C575619A

Q33947954-1E2BEA49-B2A2-4BB6-B9ED-30405C1EEAE8

Q33947954-20A80F4F-6F94-4BBA-9677-10E29D807A0D

Q33947954-21F30D6E-06BD-42A8-BFE5-306D03C980EC

Q33947954-25FFF38E-6D22-4B0E-990B-49D17914EF2C

Q33947954-2A06C0A7-2A59-45A9-BB0D-DD6410AFF977

Q33947954-32AC3480-7B66-4BB6-B349-3CCB0876D3C0

P304

Q33947954-373536FC-BB99-4D2E-9A3B-09D02A0531E8

P31

Q33947954-CF6B6B40-0DDD-4377-BB69-8DF5F0E7B0EA

P356

Q33947954-5BEB4B4A-9818-4B4A-A2DE-B2B543120DA9

P433

Q33947954-C39F8C8F-E105-4F3F-89FC-3C8DCD5E4F20

P478

Q33947954-53CB0630-CFDD-4BA7-96D2-49FD8971922B

P50

Q33947954-4D3815B6-C959-4DBA-9FA4-223099A59AC1

Q33947954-9F91ECB8-CAE2-415B-83A5-87B236D50B9F

Q33947954-D7B3D685-A92F-42FB-8E7D-985D054FF0AA

P577

Q33947954-97EF4066-6254-4E70-9444-F5ABABB9BED5

P5875

Q33947954-BF4E6984-46A6-48C5-B0A4-5ED8E9776618

P698

Q33947954-A0C51EE9-B86F-4D89-A406-0CABE9EA0007

P932

Q33947954-DED616B7-3CB7-4977-8E4B-D1F776826049

P356

P1433

Human Molecular Genetics

P1476

iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function

@en

P2093

Akemi Ishida-Yamamoto

http://www.w3.org/2001/XMLSchema#string

Charlotte Simpson

http://www.w3.org/2001/XMLSchema#string

Nihal Kaplan

http://www.w3.org/2001/XMLSchema#string

Olivier Marches

http://www.w3.org/2001/XMLSchema#string

Sarah L Etheridge

http://www.w3.org/2001/XMLSchema#string

Spiro Getsios

http://www.w3.org/2001/XMLSchema#string

P2860

Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling

TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells

RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing

Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes

P304

4064-4076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDU120

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

David P. Kelsell

Matthew A Brooke

P577

2014-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260916036

http://www.w3.org/2001/XMLSchema#string

P698

24643277

http://www.w3.org/2001/XMLSchema#string

P932

4110483

http://www.w3.org/2001/XMLSchema#string